Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant
Clinical trial NCT00248547 · COMPLETED
Trial details
- NCT number
- NCT00248547
- Sponsor
- OHSU Knight Cancer Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2009-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.